Bayer, Monsanto agree to $9 billion asset sale to win US clearance
German chemical and pharmaceutical company Bayer has agreed to sell approximately $9 billion in assets to address concerns the Department of Justice had with its proposed acquisition of US agricultural company...To view the full article, register now.
Already a subscriber? Click here to view full article